Biomaxima SA (BMX) Financial Statements
Biomaxima SA Financial Overview
Biomaxima SA's market cap is currently $39.37M. The company's EPS TTM is $0.19; its P/E ratio is 48.91; and it has a dividend yield of 2.14%. Biomaxima SA is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 60.90M | $ 52.85M | $ 46.79M | $ 143.87M | $ 79.09M |
| Gross Profit | $ 1.67M | $ 23.26M | $ 20.02M | $ 54.23M | $ 28.99M |
| Operating Income | $ -135.00K | $ 1.31M | $ 728.00K | $ 34.85M | $ 13.65M |
| EBITDA | $ 3.57M | $ 4.65M | $ 3.28M | $ 38.36M | $ 14.69M |
| Net Income | $ 105.00K | $ 535.00K | $ 586.00K | $ 28.89M | $ 10.24M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.74M | $ 909.00K | $ 1.50M | $ 12.92M | $ 3.01M |
| Total Assets | $ 77.47M | $ 76.34M | $ 73.78M | $ 74.42M | $ 61.93M |
| Total Debt | $ 14.46M | $ 14.62M | $ 12.86M | $ 5.83M | $ 17.27M |
| Net Debt | $ 12.72M | $ 13.71M | $ 11.36M | $ -7.08M | $ 16.96M |
| Total Liabilities | $ 23.75M | $ 29.01M | $ 26.81M | $ 21.96M | $ 32.74M |
| Stockholders' Equity | $ 48.08M | $ 47.33M | $ 46.97M | $ 52.46M | $ 29.19M |
| Cash Flow | |||||
| Free Cash Flow | $ 1.34M | $ -2.42M | $ -16.49M | $ 27.19M | $ -4.61M |
| Operating Cash Flow | $ 2.34M | $ -152.00K | $ 1.59M | $ 37.06M | $ -132.00K |
| Investing Cash Flow | $ 1.30M | $ -759.00K | $ -17.25M | $ -7.83M | $ -3.37M |
| Financing Cash Flow | $ -2.81M | $ 317.00K | $ 4.25M | $ -19.32M | $ 2.11M |
Currency in PLN